Gendelman HE - Search Results

1

Neurodegenerative disorders and nanoformulated drug development.

Nowacek A, Kosloski LM, Gendelman HE. Nowacek A, et al. Among authors: gendelman he. Nanomedicine (Lond). 2009 Jul;4(5):541-55. doi: 10.2217/nnm.09.37. Nanomedicine (Lond). 2009. PMID: 19572820 Free PMC article. Review.

2

Innate and acquired immunity in neurodegenerative disorders.

Gendelman HE, Folks DG. Gendelman HE, et al. J Leukoc Biol. 1999 Apr;65(4):407-8. doi: 10.1002/jlb.65.4.407. J Leukoc Biol. 1999. PMID: 10204567 Review. No abstract available.

3

Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases.

Kadiu I, Glanzer JG, Kipnis J, Gendelman HE, Thomas MP. Kadiu I, et al. Among authors: gendelman he. Neurotox Res. 2005 Oct;8(1-2):25-50. doi: 10.1007/BF03033818. Neurotox Res. 2005. PMID: 16260384 Review.

4

Oxidative stress and the pathogenesis of neurodegenerative disorders.

Reynolds A, Laurie C, Mosley RL, Gendelman HE. Reynolds A, et al. Among authors: gendelman he. Int Rev Neurobiol. 2007;82:297-325. doi: 10.1016/S0074-7742(07)82016-2. Int Rev Neurobiol. 2007. PMID: 17678968 Review.

5

Biomarkers, laboratory, and animal models for the design and development of adjunctive therapies for HIV-1 dementia and other neuroinflammatory disorders.

Gendelman HE. Gendelman HE. J Neuroimmune Pharmacol. 2007 Mar;2(1):8-13. doi: 10.1007/s11481-006-9050-2. Epub 2007 Jan 9. J Neuroimmune Pharmacol. 2007. PMID: 18040820 Review.

6

CD 4+ T cells in the pathobiology of neurodegenerative disorders.

Huang X, Reynolds AD, Mosley RL, Gendelman HE. Huang X, et al. Among authors: gendelman he. J Neuroimmunol. 2009 Jun 25;211(1-2):3-15. doi: 10.1016/j.jneuroim.2009.04.006. Epub 2009 May 12. J Neuroimmunol. 2009. PMID: 19439368 Free PMC article. Review.

7

Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.

Dou H, Grotepas CB, McMillan JM, Destache CJ, Chaubal M, Werling J, Kipp J, Rabinow B, Gendelman HE. Dou H, et al. Among authors: gendelman he. J Immunol. 2009 Jul 1;183(1):661-9. doi: 10.4049/jimmunol.0900274. Epub 2009 Jun 17. J Immunol. 2009. PMID: 19535632 Free PMC article.

8

NanoART, neuroAIDS and CNS drug delivery.

Nowacek A, Gendelman HE. Nowacek A, et al. Among authors: gendelman he. Nanomedicine (Lond). 2009 Jul;4(5):557-74. doi: 10.2217/nnm.09.38. Nanomedicine (Lond). 2009. PMID: 19572821 Free PMC article. Review.

9

NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.

Nowacek AS, Miller RL, McMillan J, Kanmogne G, Kanmogne M, Mosley RL, Ma Z, Graham S, Chaubal M, Werling J, Rabinow B, Dou H, Gendelman HE. Nowacek AS, et al. Among authors: gendelman he. Nanomedicine (Lond). 2009 Dec;4(8):903-17. doi: 10.2217/nnm.09.71. Nanomedicine (Lond). 2009. PMID: 19958227 Free PMC article.

10

Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders.

Mosley RL, Gendelman HE. Mosley RL, et al. Among authors: gendelman he. Exp Neurol. 2010 Mar;222(1):1-5. doi: 10.1016/j.expneurol.2009.12.018. Epub 2010 Jan 4. Exp Neurol. 2010. PMID: 20044993 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

490 results

Search Page

Filters